Hansa Biopharma
Sweden
We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.
Private Company
Total funding raised: $185M
About
We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.
BiologicsDiagnostics
Funding History
5Total raised:$185M
PIPE$60MJun 15, 2020
IPO$50MOct 2, 2015
Series C$40MJun 15, 2013
Series B$25MJun 15, 2010